NIAGEN BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
NIAGEN BIOSCIENCE, INC. (NAGE) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 140 shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2020-03-10
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2013-09-28 was 0.00 shares.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2013-06-29 was 4.39M shares.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2013-03-30 was 3.41M shares.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2019 was 140.00 shares.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2018 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month |
|---|---|---|---|---|
| 2019-12-31 | 140.00 shares 10-K · filed 2020-03-10 | |||
| 2018-12-31 | 0.00 shares 10-K · filed 2020-03-10 | |||
| 2013-09-28 | 0.00 shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-21 | 4.39M shares derived: sum of 2 quarters · filed 2013-12-05 | 7.80M shares 10-Q · filed 2013-11-21 | |
| 2013-06-29 | 4.39M shares 10-Q/A · filed 2013-12-05 | 7.80M shares 10-Q/A · filed 2013-12-05 | ||
| 2013-03-30 | 3.41M shares 10-Q/A · filed 2013-12-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |